Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis
Abstract Background Novartis and the University of Oxford’s Big Data Institute (BDI) have established a research alliance with the aim to improve health care and drug development by making it more efficient and targeted. Using a combination of the latest statistical machine learning technology with...
Guardado en:
Autores principales: | Ann-Marie Mallon, Dieter A. Häring, Frank Dahlke, Piet Aarden, Soroosh Afyouni, Daniel Delbarre, Khaled El Emam, Habib Ganjgahi, Stephen Gardiner, Chun Hei Kwok, Dominique M. West, Ewan Straiton, Sibylle Haemmerle, Adam Huffman, Tom Hofmann, Luke J. Kelly, Peter Krusche, Marie-Claude Laramee, Karine Lheritier, Greg Ligozio, Aimee Readie, Luis Santos, Thomas E. Nichols, Janice Branson, Chris Holmes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d43dee580b834d6ca85817e178bae918 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Maternal sociodemographic characteristics, early pregnancy behaviours, and livebirth outcomes as congenital heart defects risk factors - Northern Ireland 2010-2014
por: Hafi Saad, et al.
Publicado: (2021) -
The Spatiotemporal Data Fusion (STDF) Approach: IoT-Based Data Fusion Using Big Data Analytics
por: Dina Fawzy, et al.
Publicado: (2021) -
Views on Open Data Business from Software Development Companies
por: Herala,Antti, et al.
Publicado: (2018) -
Efficient IoT Data Management for Geological Disasters Based on Big Data-Turbocharged Data Lake Architecture
por: Xiaohui Huang, et al.
Publicado: (2021) -
Exploratory data analysis in the context of data mining and resampling.
por: Chong Ho Yu
Publicado: (2010)